Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Sales (2016 - 2025)

Historic Return on Sales for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to 0.03%.

  • Immucell's Return on Sales rose 900.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.08% for FY2024, which is 2500.0% up from last year.
  • According to the latest figures from Q3 2025, Immucell's Return on Sales is 0.03%, which was up 900.0% from 0.08% recorded in Q2 2025.
  • Immucell's 5-year Return on Sales high stood at 0.18% for Q1 2025, and its period low was 0.67% during Q1 2023.
  • In the last 5 years, Immucell's Return on Sales had a median value of 0.11% in 2021 and averaged 0.13%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -7600bps in 2023, then soared by 6100bps in 2024.
  • Over the past 5 years, Immucell's Return on Sales (Quarter) stood at 0.01% in 2021, then crashed by -3232bps to 0.43% in 2022, then fell by -9bps to 0.47% in 2023, then soared by 114bps to 0.07% in 2024, then crashed by -138bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.08% for Q2 2025, and 0.18% during Q1 2025.